264 related articles for article (PubMed ID: 29090665)
1. Quinoxalinone as a Privileged Platform in Drug Development.
Shi L; Hu W; Wu J; Zhou H; Zhou H; Li X
Mini Rev Med Chem; 2018 Feb; 18(5):392-413. PubMed ID: 29090665
[TBL] [Abstract][Full Text] [Related]
2. Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives.
Ajani OO; Obafemi CA; Nwinyi OC; Akinpelu DA
Bioorg Med Chem; 2010 Jan; 18(1):214-21. PubMed ID: 19948407
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in design of potential quinoxaline anti-infectives.
Jampilek J
Curr Med Chem; 2014; 21(38):4347-73. PubMed ID: 25312209
[TBL] [Abstract][Full Text] [Related]
4. Survey of recent literature related to the biologically active 4(3H)-quinazolinones containing fused heterocycles.
Demeunynck M; Baussanne I
Curr Med Chem; 2013 Feb; 20(6):794-814. PubMed ID: 23276134
[TBL] [Abstract][Full Text] [Related]
5. Recent Methods for the Synthesis of Quinoxaline Derivatives and their Biological Activities.
Farghaly TA; Alqurashi RM; Masaret GS; Abdulwahab HG
Mini Rev Med Chem; 2024; 24(9):920-982. PubMed ID: 37885112
[TBL] [Abstract][Full Text] [Related]
6. An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Cherukupalli S; Hampannavar GA; Chinnam S; Chandrasekaran B; Sayyad N; Kayamba F; Reddy Aleti R; Karpoormath R
Bioorg Med Chem; 2018 Jan; 26(2):309-339. PubMed ID: 29273417
[TBL] [Abstract][Full Text] [Related]
7. Carbazole Scaffold in Medicinal Chemistry and Natural Products: A Review from 2010-2015.
Tsutsumi LS; Gündisch D; Sun D
Curr Top Med Chem; 2016; 16(11):1290-313. PubMed ID: 26369811
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization and Biological Evaluation of Some Quinoxaline Derivatives: A Promising and Potent New Class of Antitumor and Antimicrobial Agents.
Al-Marhabi AR; Abbas HA; Ammar YA
Molecules; 2015 Nov; 20(11):19805-22. PubMed ID: 26540036
[TBL] [Abstract][Full Text] [Related]
9. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B
Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808
[TBL] [Abstract][Full Text] [Related]
10. An insight into medicinal chemistry of anticancer quinoxalines.
Kaushal T; Srivastava G; Sharma A; Singh Negi A
Bioorg Med Chem; 2019 Jan; 27(1):16-35. PubMed ID: 30502116
[TBL] [Abstract][Full Text] [Related]
11. Quinoxaline derivatives: a patent review (2006--present).
González M; Cerecetto H
Expert Opin Ther Pat; 2012 Nov; 22(11):1289-302. PubMed ID: 22971178
[TBL] [Abstract][Full Text] [Related]
12. Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity.
Zou Y; Qin X; Hao X; Zhang W; Yang S; Yang Y; Han Z; Ma B; Zhu C
Bioorg Med Chem Lett; 2015 Sep; 25(18):3924-7. PubMed ID: 26227780
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Miyashiro J; Woods KW; Park CH; Liu X; Shi Y; Johnson EF; Bouska JJ; Olson AM; Luo Y; Fry EH; Giranda VL; Penning TD
Bioorg Med Chem Lett; 2009 Aug; 19(15):4050-4. PubMed ID: 19553114
[TBL] [Abstract][Full Text] [Related]
14. Medicinal significance of benzothiazole scaffold: an insight view.
Sharma PC; Sinhmar A; Sharma A; Rajak H; Pathak DP
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):240-66. PubMed ID: 23030043
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity.
Galal SA; Khairat SH; Ragab FA; Abdelsamie AS; Ali MM; Soliman SM; Mortier J; Wolber G; El Diwani HI
Eur J Med Chem; 2014 Oct; 86():122-32. PubMed ID: 25147154
[TBL] [Abstract][Full Text] [Related]
16. Quinoxaline: An insight into the recent pharmacological advances.
Tariq S; Somakala K; Amir M
Eur J Med Chem; 2018 Jan; 143():542-557. PubMed ID: 29207337
[TBL] [Abstract][Full Text] [Related]
17. Biological potential of carbazole derivatives.
Głuszyńska A
Eur J Med Chem; 2015 Apr; 94():405-26. PubMed ID: 25794500
[TBL] [Abstract][Full Text] [Related]
18. An efficient synthesis of quinoxalinone derivatives as potent inhibitors of aldose reductase.
Yang Y; Zhang S; Wu B; Ma M; Chen X; Qin X; He M; Hussain S; Jing C; Ma B; Zhu C
ChemMedChem; 2012 May; 7(5):823-35. PubMed ID: 22416050
[TBL] [Abstract][Full Text] [Related]
19. Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity.
El Newahie AM; Ismail NS; Abou El Ella DA; Abouzid KA
Arch Pharm (Weinheim); 2016 May; 349(5):309-26. PubMed ID: 27062086
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antimicrobial Activity of Some New Substituted Quinoxalines.
El-Atawy MA; Hamed EA; Alhadi M; Omar AZ
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
